- US12583906utility2026Actrii Proteins and Use in Treating Post-capillary Pulmonary Hypertension0 cites
- US12545736utility2026Actrii-binding Proteins and Uses Thereof0 cites
- US12527839utility2026Treatments for Systemic Sclerosis0 cites
- US12421295utility2025Tgf-beta Superfamily Type I and Type II Receptor Heteromultimers and Uses Thereof0 cites
- US12365736utility2025ALK7 Binding Proteins and Uses Thereof0 cites
- US12343378utility2025Compositions and Methods for Treating Pulmonary Hypertension0 cites
- US12258380utility2025Alk4:actriib Heteromultimers and Uses Thereof0 cites
- US12240887utility2025Variant Actriib Proteins and Uses Thereof0 cites
- US12194076utility2025Methods and Compositions for Treating Myelofibrosis0 cites
- US12195519utility2025Transforming Growth Factor-beta (tgf-beta) Receptor Type II Fusion Polypeptides0 cites
- US12168683utility2024Binders of Tgfβ-superfamily Ligands and Uses Thereof0 cites
- US12144860utility2024ALK1 Receptor and Ligand Antagonists and Uses Thereof0 cites
- US12145970utility2024Twisted Gastrulation Polypeptides and Uses Thereof0 cites
- US12103959utility2024Multispecific Binders of Tgfbeta-superfamily Ligands and Uses Thereof0 cites
- US12054753utility2024Methods of Treatment of Muscular Dystrophy with Alk4:actriib Heteromultimers0 cites
- US12042524utility2024Activin Type 2 Receptor Binding Proteins Methods of Making Them0 cites
- US12024563utility2024ALK7 Antagonists and Uses Thereof0 cites
- US11981738utility2024ALK7 Binding Proteins and Uses Thereof0 cites
- US11976111utility2024Actriia and ALK4 Polypeptides for Treating Kidney Fibrosis, Inflammation and Injury0 cites
- US11951156utility2024Methods for Treating Pulmonary Hypertension with a Ligand Binding Domain of a Tgf-beta Type II Receptor0 cites
Page 1 of 2Next →